CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,598,184 | -20.4% | 226,400 | +0.4% | 0.39% | -25.5% |
| Q3 2022 | $5,779,000 | -2.4% | 225,400 | -9.5% | 0.52% | +10.1% |
| Q2 2022 | $5,922,000 | +6.2% | 249,000 | +0.6% | 0.47% | +31.7% |
| Q1 2022 | $5,576,000 | +72.8% | 247,600 | +33.5% | 0.36% | +13.9% |
| Q3 2020 | $3,226,000 | +3.4% | 185,400 | 0.0% | 0.32% | +11.3% |
| Q2 2020 | $3,119,000 | +136.1% | 185,400 | +130.9% | 0.28% | +54.3% |
| Q1 2018 | $1,321,000 | -19.0% | 80,300 | -11.1% | 0.18% | -30.0% |
| Q4 2017 | $1,631,000 | -6.4% | 90,300 | 0.0% | 0.26% | -10.5% |
| Q3 2017 | $1,743,000 | +63.5% | 90,300 | 0.0% | 0.29% | +41.3% |
| Q2 2017 | $1,066,000 | -5.8% | 90,300 | -12.6% | 0.21% | -7.6% |
| Q1 2017 | $1,132,000 | – | 103,300 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |